Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application Study on the Safety and Feasibility of Transcatheter Injectable Protein Alginate-based Hydrogel for Alleviating Reperfusion Injury in Acute STEMI

NCT07601997 is registered in ClinicalTrials.gov with Myomed Technology (Shaoxing) Co., Ltd. as lead sponsor.

NCT NCT07601997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07601997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application Study on the Safety and Feasibility of Transcatheter Injectable Protein Alginate-based Hydrogel for Alleviating Reperfusion Injury in Acute STEMI
Lead sponsor
Myomed Technology (Shaoxing) Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 30, 2026
Completion date
April 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stemi - st elevation myocardial infarction